MARCELITA TORRES: Open Payments
NPI 1417109513 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 18 payments from 11 companies in 2025. Trend: 2023 $628 · 2024 $603 · 2025 $1,365
Food & beverage: $1,365
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $266 |
| AstraZeneca Pharmaceuticals LP | 3 | $263 |
| Boston Scientific Corporation | 1 | $136 |
| Amgen Inc. | 1 | $122 |
| Dexcom, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 1 | $100 |
| Medtronic, Inc. | 1 | $82 |
| Stryker Corporation | 2 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
Products named: Ozempic, WATCHMAN FLX, BREZTRI, FASENRA, OTEZLA, DEXCOM G7 GSS (161), Kerendia, SYNCHROMEDII.
Industry payments across TX — which companies pay providers there.
